These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7538005)

  • 1. The search for susceptibility genes of COPD.
    Luisetti M; Pignatti PF
    Monaldi Arch Chest Dis; 1995 Jan; 50(1):28-32. PubMed ID: 7538005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology: a key to better understanding of chronic obstructive lung disease.
    Snider GL
    Monaldi Arch Chest Dis; 1995 Jan; 50(1):3-6. PubMed ID: 7538006
    [No Abstract]   [Full Text] [Related]  

  • 3. [Genetic risk factors for chronic obstructive pulmonary disease (COPD)].
    Miki M; Satoh K
    Nihon Rinsho; 1999 Sep; 57(9):1954-8. PubMed ID: 10497389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of chronic obstructive pulmonary disease.
    Silverman EK
    Novartis Found Symp; 2001; 234():45-58; discussion 58-64. PubMed ID: 11199103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial predisposition to chronic obstructive pulmonary disease].
    Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 2009; 77(4):407-10. PubMed ID: 19722147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease.
    Benetazzo MG; Gilè LS; Bombieri C; Malerba G; Massobrio M; Pignatti PF; Luisetti M
    Respir Med; 1999 Sep; 93(9):648-54. PubMed ID: 10542979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic risk factors for chronic obstructive pulmonary disease.
    Sandford AJ; Weir TD; Paré PD
    Eur Respir J; 1997 Jun; 10(6):1380-91. PubMed ID: 9192947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inspired respiratory solutions.
    Geisow MJ
    Trends Biotechnol; 1992 Jun; 10(6):181-2. PubMed ID: 1379819
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.
    Silverman EK; Chapman HA; Drazen JM; Weiss ST; Rosner B; Campbell EJ; O'DONNELL WJ; Reilly JJ; Ginns L; Mentzer S; Wain J; Speizer FE
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1770-8. PubMed ID: 9620904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis.
    Mahadeva R; Sharples L; Ross-Russell RI; Webb AK; Bilton D; Lomas DA
    Thorax; 2001 Jan; 56(1):53-8. PubMed ID: 11120905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the PiF allele of alpha 1-antitrypsin associated with pulmonary disease?
    Beckman G; Stjernberg NL; Eklund A
    Clin Genet; 1984 Jun; 25(6):491-5. PubMed ID: 6610506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial aggregation in chronic obstructive pulmonary disease: use of the loglinear model to analyze intermediate environmental and genetic risk factors.
    Khoury MJ; Beaty TH; Tockman MS; Self SG; Cohen BH
    Genet Epidemiol; 1985; 2(2):155-66. PubMed ID: 3876967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between alpha-1-antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease.
    Ishii T; Matsuse T; Teramoto S; Matsui H; Hosoi T; Fukuchi Y; Ouchi Y
    Eur J Clin Invest; 2000 Jun; 30(6):543-8. PubMed ID: 10849024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for the development of chronic obstructive pulmonary disease.
    Silverman EK; Speizer FE
    Med Clin North Am; 1996 May; 80(3):501-22. PubMed ID: 8637301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease.
    Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC
    Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease.
    Mahadeva R; Westerbeek RC; Perry DJ; Lovegrove JU; Whitehouse DB; Carroll NR; Ross-Russell RI; Webb AK; Bilton D; Lomas DA
    Eur Respir J; 1998 Apr; 11(4):873-9. PubMed ID: 9623690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic-epidemiologic study of chronic obstructive pulmonary disease. I. Study design and preliminary observations.
    Cohen BH; Ball WC; Bias WB; Brashears S; Chase GA; Diamond EL; Hsu SH; Kreiss P; Levy DA; Menkes HA; Permutt S; Tockman MS
    Johns Hopkins Med J; 1975 Sep; 137(3):95-104. PubMed ID: 1081163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease.
    Gasparini P; Savoia A; Luisetti M; Peona V; Pignatti PF
    Am J Respir Cell Mol Biol; 1990 Mar; 2(3):297-9. PubMed ID: 1968751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complex search for antiprotease-protease enzyme gene polymorphisms in patients with chronic obstructive pulmonary diseases].
    Ianbaeva DG; Korytina GF; Viktorova TV
    Mol Biol (Mosk); 2004; 38(6):973-9. PubMed ID: 15612581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.